Nuvalent, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense):
Change in fair value of preferred stock tranche rights
Other income (expense), net
Interest income and other income, net
Change in fair value of related party revenue share liability
Interest income and other income (expense), net
Total other income (expense), net

Loss before income taxes
Income tax provision
Net loss
Other comprehensive income (loss):
Unrealized gains (losses) on marketable securities
Comprehensive loss
Net loss per share attributable to Class A and Class B common stockholders, basic
Net loss per share attributable to Class A and Class B common stockholders, diluted
Weighted average shares of Class A and Class B common stock outstanding, basic
Weighted average shares of Class A and Class B common stock outstanding, diluted

Comments